DOTAREM 0

DRUG3 trials

Sponsors

Radboud universitair medisch centrum Stichting, Guerbet, Bracco Imaging S.p.A., Fundacio Sant Joan De Deu

Conditions

Breast CancerCardiomyopathySuspected Vascular Disease of supra-aortic (carotid/vertebrobasilar)or complex congenital heart diseaseperipheral or abdominal/renal arteriestetralogy of Fallot

Phase 3

Efficacy of Reduced Gadolinium Dose in Contrast-Enhanced Breast MRI

RecruitingCTIS2024-518549-27-00

Radboud universitair medisch centrum StichtingBreast Cancer

Start: 2025-08-14Target: 100Updated: 2025-02-20

A Pilot Study on the Use of Gadopiclenol for Enhanced Cardiac MRI in Children with Congenital Heart Conditions: A self-controlled, non-randomised, open-label study to compare the image quality and diagnostic performance of gadopiclenol versus gadoterate meglumine

Not yet recruitingCTIS2025-524029-41-00

Fundacio Sant Joan De DeuCardiomyopathy, or complex congenital heart disease, tetralogy of Fallot

Target: 30Updated: 2026-02-02

A Prospective, Multi-National, Randomized, Double-Blind, Crossover Study to Evaluate the Efficacy and Safety of Gadopiclenol-enhanced MRA Compared to Gadoterate Meglumine-enhanced MRA in the Assessment of Steno-occlusive Disease in Adult Patients with Suspected Vascular Disease

Not yet recruitingCTIS2024-518835-13-00

Guerbet, Bracco Imaging S.p.A.peripheral or abdominal/renal arteries, Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar)

Target: 40Updated: 2026-04-15